Open access
Open access
Powered by Google Translator Translator

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant

2 Feb, 2021 | 01:29h | UTC

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant – The BMJ

 

Commentary on Twitter

 


Stay Updated in Your Specialty

No spam, just news.